Ominimo Secures $11M Investment From Zurich Insurance Group At €200M Valuation

Poland-based AI insurtech startup Ominimo, led by CEO and co-founder Dusan Komar, has secured its first external investment—an €10M ($11M) equity round from Zurich Insurance Group, valuing the company at €200M ($220M). Launched just a year ago and already profitable, Ominimo has sold 300,000 car insurance policies in Hungary and holds a 7% market share. Built by Komar alongside co-founders Dennis Weinbender (Chief Pricing & Data Officer) and Laslo Horvath (CTO), the company leverages AI and big-data analytics to redefine risk assessment. Backed by Zurich, Ominimo plans to expand across 10+ new markets, starting with Poland, Sweden, and the Netherlands. INVESTOR: Zurich Insurance Group AMOUNT: $11,000,000 HQ: #Warsaw #Poland #VentureCapital #Ominimo #DusanKomar #ZurichInsuranceGroup #TradedVC

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC